Aspirin and Cardiovascular Risk in Individuals With Elevated Lipoprotein(a): The Multi‐Ethnic Study of Atherosclerosis
Background Effective therapies for reducing cardiovascular disease (CVD) risk in people with elevated lipoprotein(a) are lacking, especially for primary prevention. Because of the potential association of lipoprotein(a) with thrombosis, we evaluated the relationship between aspirin use and CVD event...
Main Authors: | Harpreet S. Bhatia, Patrick Trainor, Samantha Carlisle, Michael Y. Tsai, Michael H. Criqui, Andrew DeFilippis, Sotirios Tsimikas |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-02-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.123.033562 |
Similar Items
-
Is there a benefit of aspirin therapy for primary prevention to reduce the risk of atherosclerotic cardiovascular disease in patients with elevated Lipoprotein (a)—A review of the evidence
by: Mohamad Hekmat Sukkari, et al.
Published: (2023-09-01) -
Small dense low-density lipoprotein cholesterol compared to other lipoprotein biomarkers for predicting coronary heart disease among individuals with normal fasting glucose: The Multi-Ethnic Study of Atherosclerosis
by: Sarah O. Nomura, et al.
Published: (2023-03-01) -
Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events
by: Peter Willeit, et al.
Published: (2020-12-01) -
Aspirin: yesterday, today, and tomorrow
by: Marina Nikołajewna Dołżenko
Published: (2014-06-01) -
Aspirin : the miracle drug /
by: 296334 Metcalf, Eric
Published: (2005)